In this review, we introduce nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and epidermal growth factor receptor (EGFR) as molecular targets that can complement antioxidant activity and effectively inhibit skin cancer via the regulation of various signaling networks. This evidence concerns the gene EGFR and skin neoplasm.